medigraphic.com
ISSN 1561-2929 (Print)

2019, Number 2

<< Back Next >>

RCAN 2019; 29 (2)

Intervalos de referencia para la cistatina C sérica en la población adulta cubana

Darias RD

Language: Spanish
References: 55
Page: 542-557
PDF size: 1117.06 Kb.


ABSTRACT

No Abstract.


REFERENCES

  1. Simonsen O, Grubb A, Thysell H. The blood serum concentration of cystatin C (gamma-trace) as a measure of the glomerular filtration rate. Scand J Clin Lab Invest 1985;45:97-101.

  2. Martínez Bru C. Cistatina C. Propiedades y utilidad clínica. Ed Cont Lab Clín 2006;9:36-41.

  3. García MF, Coll E, Pedret SV, Guitarte CB, Fernández MCC, Rius MC; et al. Cistatina C en la evaluación de la función renal. Rev Lab Clín 2011;4: 50-62.

  4. Fraga Rodríguez G. La determinación de los valores plasmáticos de cistatina C como método de valoración de la función renal en Pediatría. An Pediatr Contin 2012;10:95-100.

  5. Inker LA. Estimating glomerular filtration rate from serum creatinine and cystatin C. New Engl J Med 2012;367: 20-9.

  6. Fliser D, Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kid Dis 2001;37:79-83.

  7. Takeuchi M, Fukuda Y, Nakano I, Katano Y, Hayakawa T. Elevation of serum cystatin C concentrations in patients with chronic liver disease. Eur J Gastroenterol Hepatol 2001;13: 951-5.

  8. Overton ET, Patel P, Mondy K, Bush T, Conley L, Rhame F; et al.; for the SUN Study Investigators Joint Task Force. Cystatin C and baseline renal function among HIV-infected persons in the SUN Study. AIDS Res Human Retrovir 2012; 28:148-55.

  9. Ix JH, Shlipak MG, Chertow GM, Whooley MA. Association of Cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: Data from the Heart and Soul Study. Circulation 2007;115:173-9.

  10. Rodilla E, Costa JA, Pérez Lahiguera F, González C, Miralles A, Pascual JM. Relación del cistatina C con otros parámetros de riesgo vascular en pacientes con hipertensión arterial. Medicina Clínica [Barcelona] 2008;130: 6-9.

  11. García Sánchez N, León Álvarez JL. Sobre el comportamiento de biomarcadores de la arteriosclerosis en la hipertensión arterial. RCAN Rev Cubana Aliment Nutr 2016:26:252-74.

  12. Zhang Z, Lu B, Sheng X, Jin N. Cystatin C in prediction of acute kidney injury: A systemic review and meta-analysis. Am J Kidney Dis 2012;59:590-2.

  13. Seijas M, Lorente JA, Baccino C. Definición y biomarcadores de daño renal agudo: Nuevas perspectivas. Medicina Intensiva [Barcelona] 2014;38:376-85. Disponible en: http://doi:10.1016/j.medin.2013.09.001. Fecha de última actualización: 14 de Febrero del 2018.

  14. Grubb A, Bjork J, Lindstrom V, Sterner G, Bondesson P, Nyman U. A cystatin C-based formula without anthropometric variables estimates glomerular filtration rate better than creatinine clearance using the Cockcroft-Gault formula. Scand J Clin Lab Invest 2005;65:153-62.

  15. Grubb A, Nyman U, Bjork J, Lindstrom V, Rippe B, Sterner G; et al. Simple cystatin C-based prediction equations for glomerular filtration rate compared with the Modification of Diet in Renal Disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children. Clin Chem 2005;51:1420-31.

  16. Borges RL, Hirota AH, Quinto BM, Ribeiro AB, Zanella MT, Batista MC. Is cystatin C a useful marker in the detection of diabetic kidney disease? Nephron Clin Pract 2010; 114(2):c127-c134.

  17. Malheiro J, Fonseca I, Martins LS, Almeida M, Pedroso S, Dias L; et al. A comparison between serum creatinine and cystatin C-based equations for estimation of graft function. Transplant Proc 2010;44:2352-6.

  18. Sharma AP, Kathiravelu A, Nadarajah R, Yasin A, Filler G. Body mass does not have a clinically relevant effect on cystatin C eGFR in children. Nephrol Dial Transplant 2009;24:470-4.

  19. Meeusen JW, Rule AD, Voskoboev N, Baumann NA, Lieske JC. Performance of cystatin C–and creatinine-based estimated glomerular filtration rate equations depends on patient characteristics. Clin Chem 2015;61: 1265-72.

  20. Horn PS, Pesce AJ. Reference intervals: An update. Clin Chim Acta 2003;334: 5-23.

  21. Solberg HE. The IFCC recommendation on estimation of reference intervals. The RefVal program. Clin Chem Lab Med 2004;42:710-4.

  22. Horowitz GL. Defining, establishing, and verifying reference intervals in the clinical laboratory; proposed guideline. CLSI document C28-P3. Third Edition. Clinical and Laboratory Standards Institute. Wayne [Pensylvania]: 2008.

  23. Cruz C. Valores de referencia. En: Laboratorio Clínico [Editores: Cruz C, Suardíaz J]. Editorial Ciencias Médicas. La Habana: 2004. pp. 61-65.

  24. Aytekin M, Emerk K. Accurate reference intervals are required for accurate diagnosis and monitoring of patients. EJIFCC 2008;19(2):137-137. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975208/. Fecha de última visita: 16 de Febrero del 2018.

  25. Reinhard M, Erlandsen EJ, Randers E. Biological variation of cystatin C and creatinine. Scand J Clin Lab Invest 2009; 69:831-6.

  26. Galteau M, Guyon M, Gueguen R, Siest G. Determination of serum cystatin C: Biological variation and reference values. Clin Chem Lab Med. 2001;39: 850-7.

  27. Croda-Todd MT, Soto-Montano XJ, Hernández-Cancino PA, Juárez-Aguilar E. Adult cystatin C reference intervals determined by nephelometric immunoassay. Clin. Biochem 2007;40: 1084-7.

  28. Miller WG, Myers GL, Gantzer ML, Kahn SE, Schönbrunner ER, Thienpont LM. Roadmap for harmonization of clinical laboratory measurement procedures. Clin Chem 2012;57:1108-17. Disponible en: http://dx.doi.org/10.1373/clinchem.2011.164012. Fecha de última visita: 16 de Febrero del 2018.

  29. Fuentes X. Valores de referencia biológicos, acreditación y armonización. Laboratorio Clínico 2012;5:55-6. Disponible en: http://doi:10.1016/j.labcli.2011.10.003. Fecha de última visita: 16 de Febrero del 2018.

  30. International Federation of Clinical Chemistry and Laboratory Medicine. Statement on the use of ISO 15189 in the accreditation of medical laboratories. Disponible en: http://www.ifcc.org/pdf/iso15189_c-clm.pdf. Fecha de última visita: 22 de Octubre del 2018.

  31. Kolmogorov A. Sulla determinazione empirica di una legge di distribuzione. G Inst Ital Attuari 1933;4:83.

  32. Smirnov NV. Tables for estimating the goodness of fit of empirical distributions. Ann Math Stat 1948;19:279.

  33. Manning WG, Mullahy J. Estimating log models: To transform or not to transform? J Health Econom 2001;20: 461-94.

  34. Box GEP, Cox DR. An analysis of transformations. J Roy Stat Soc B Series 1964;26:211-34.

  35. Efron B. Nonparametric standard errors and confidence intervals. Canad J Stat 1981;9:139-58.

  36. Santana Porbén S, Martínez Canalejo H. Manual de Procedimientos Bioestadísticos. Segunda Edición. EAE Editorial Académica Española. ISBN-13:9783659059629. ISBN-10: 3659059625. Madrid: 2012.

  37. Santana Porbén S, Martínez Canalejo H. Manual de Estadísticas no Paramétricas. Editorial Publicia. Saarbrücken: 2013. ISBN: 978-3-639-55468-7.

  38. Solberg HE. A guide to IFCC recommendations on reference values. Clin Chim Acta 1993;5:162-5.

  39. Aarsand AK, Sandberg S. How to achieve harmonisation of laboratory testing- The complete picture. Clin Chim Acta 2014;432:8-14.

  40. Walton RM. Subject‐based reference values: Biological variation, individuality, and reference change values. Vet Clin Pathol 2012;41:175-81.

  41. Fraser CG. Inherent biological variation and reference values. Clin Chem Lab Med 2004;42:758-64.

  42. Vinge E, Lindergård B, Nilsson-Ehle P, Grubb A. Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adults. Scand J Clin Lab Invest 1999;59:587-92.

  43. Finney H, Newman DJ, Thakkar H, Fell JME, Price CP. Reference ranges for plasma cystatin C and creatinine measurements in premature infants, neonates, and older children. Arch Dis Child 2000;82:71-5.

  44. Roos JF, Doust J, Tett SE, Kirkpatrick CM. Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children- A meta-analysis. Clin Biochem 2007;40:383-91.

  45. Evangelopoulos AA, Vallianou NG, Bountziouka VP, Giotopoulou AN, Bonou MS, Barbetseas J; et al. The impact of demographic characteristics and lifestyle in the distribution of cystatin C values in a healthy Greek adult population. Cardiol Res Pract 2011:2011. Disponible en: https://www.hindawi.com/journals/crp/2011/163281/abs/. Fecha de última visita: 16 de Febrero del 2018.

  46. Ognibene A, Mannucci E, Caldini A, Terreni A, Brogi M, Bardini G; et al. Cystatin C reference values and aging. Clin Biochem 2006;39:658-61.

  47. Karvanen J. The statistical basis of laboratory data normalization. DIJ Drug Inf J 2003;37: 101-7.

  48. de la Presa BG, Reverter FC, Poblador SE, Tomás FJG, Álvarez SI, Martínez RML; et al. Procedimiento para la transferencia y revisión de intervalos de referencia biológicos. Rev Lab Clín 2017;10:91-4.

  49. Groth T, de Verdier CH. Transferability of clinical laboratory data. Upsala J Med Sci 1993;98:259-74.

  50. Sweeting TJ. On the choice of prior distribution for the Box-Cox transformed linear model. Biometrika 1984;71: 127-34.

  51. Wade AM, Ades AE. Age‐related reference ranges: Significance tests for models and confidence intervals for centiles. Stat Med 1994;13:2359-67.

  52. Salabarría JS, Santana S, Martinez H, Benitez LM. Intervalos de predicción como valores de referencia para la creatinina sérica en una población infantil. Bol Med Hosp Infant Mex 1997; 54:115-23.

  53. Santana-Porbén S. Valores locales de referencia para la excreción urinaria de creatinina: Una actualización. Rev Cubana Aliment Nutr 2014;24:220-30.

  54. Monteagudo-Rodríguez Y, Santana-Porbén S, Salabarría-González JR. Intervalos locales de referencia para la excreción urinaria de creatinina en niños y adolescentes cubanos. Rev Cubana Aliment Nutr 2015;25(1 Suppl 1):S59-S90.

  55. Álvarez Porbén S, González Marrero A, Valdivieso Valdivieso JP, Santana Porbén S. Reference values for spirometric variables for allegedly healthy workers. Rev Fac Med Bogotá 2018;66:179-85.




2020     |     www.medigraphic.com